RNAi for Therapeutic Market 2017 Global Analysis, Opportunities and Forecast To 2022
RNAi for Therapeutic -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022
Pune , India – April 5, 2017 /MarketersMedia/ —
RNAi for Therapeutic Industry
Description
Wiseguyreports.Com Adds “RNAi for Therapeutic -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database
The Global RNAi for Therapeutic Consumption Market 2016 Industry Trend and Forecast 2021 is a professional and in-depth study on the current state of the RNAi for Therapeutic market
The report provides a basic overview of the RNAi for Therapeutic industry including definitions, classifications, applications and industry chain structure.
Development policies and plans are discussed as well as manufacturing processes are also analyzed.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/1026276-global-rnai-for-therapeutic-consumption-market-2016-industry-trend-and-forecast
The report then analyzes the global RNAi for Therapeutic expenses, and the sales segment market is also discussed by product type, applications and region.
The major RNAi for Therapeutic market (including United States, Europe, etc.) is analyzed, data including market size, expenses segment market by product type and applications. Then we forecast the 2016-2025 market size of RNAi for Therapeutic.
The report focuses on global major leading companies providing information such as company profiles, expenses, R&D expenses and contact information.
Finally the marketing, feasibility of new investment projects are assessed and overall research conclusions offered.
With 163 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Leave a Query @ https://www.wiseguyreports.com/enquiry/1026276-global-rnai-for-therapeutic-consumption-market-2016-industry-trend-and-forecast
Table of Contents
1 Industry Overview 1
1.1 Definition and Specifications of RNAi for Therapeutic 1
1.1.1 Definition of RNAi for Therapeutic 1
1.1.2 Mechanism and Development History RNAi for Therapeutic 2
1.2 Classification of RNAi for Therapeutic 2
1.2.1 siRNA 3
1.2.2 miRNA 4
1.2.3 shRNA 5
1.3 Applications of RNAi for Therapeutic 7
1.3.1 Cancer 8
1.3.2 Cardiovascular 8
1.3.3 HBV 9
1.4 Industry Chain Structure of RNAi for Therapeutic 10
1.5 Industry Overview and Major Regions Status of RNAi for Therapeutic 10
1.5.1 Industry Overview of RNAi for Therapeutic 10
1.5.2 Global Major Regions Status of RNAi for Therapeutic 12
1.6 Industry Policy Analysis of RNAi for Therapeutic 12
1.7 Industry News Analysis of RNAi for Therapeutic 13
….
9 Analysis of RNAi for Therapeutic Industry Key Manufacturers 63
9.1 Alnylam Pharmaceuticals 63
9.1.1 Company Profile 63
9.1.2 Research Information 64
9.1.3 Expenses, R&D Expenses and R&D Share 64
9.2 Arbutus Biopharma (Tekmira) 66
9.2.1 Company Profile 66
9.2.2 Research Information 66
9.2.3 Expenses, R&D Expenses and R&D Share 67
9.3 Arrowhead Research 69
9.3.1 Company Profile 69
9.3.2 Research Information 70
9.3.3 Expenses, R&D Expenses and R&D Share 70
9.4 Dicerna Pharmaceuticals 72
9.4.1 Company Profile 72
9.4.2 Research Information 73
9.4.3 Expenses, R&D Expenses and R&D Share 73
9.5 Mirna Therapeutics 75
9.5.1 Company Profile 75
9.5.2 Research Information 76
9.5.3 Expenses, R&D Expenses and R&D Share 76
9.6 Quark Pharmaceuticals 78
9.6.1 Company Profile 78
9.6.2 Research Information 79
9.6.3 Expenses, R&D Expenses and R&D Share 79
9.7 RXi Pharmaceuticals 81
9.7.1 Company Profile 81
9.7.2 Research Information 82
9.7.3 Expenses, R&D Expenses and R&D Share 83
9.8 Silence Therapeutics 84
9.8.1 Company Profile 84
9.8.2 Research Information 85
9.8.3 Expenses, R&D Expenses and R&D Share 86
9.9 Benitec Biopharma 87
9.9.1 Company Profile 87
9.9.2 Research Information 88
9.9.3 Expenses, R&D Expenses and R&D Share 88
9.10 miRagen Therapeutics 90
9.10.1 Company Profile 90
9.10.2 Research Information 91
9.10.3 Expenses, R&D Expenses and R&D Share 92
9.11 Sylentis 93
9.11.1 Company Profile 93
9.11.2 Research Information 94
9.11.3 Expenses, R&D Expenses and R&D Share 95
9.12 Gradalis 96
9.12.1 Company Profile 96
9.12.2 Research Information 97
9.12.3 Expenses, R&D Expenses and R&D Share 97
9.13 Sirnaomics 99
9.13.1 Company Profile 99
9.13.2 Research Information 100
9.13.3 Expenses, R&D Expenses and R&D Share 100
9.14 Silenseed 102
9.14.1 Company Profile 102
9.14.2 Research Information 103
9.14.3 Expenses, R&D Expenses and R&D Share 103
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1026276
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Contact Info:
Name: NORAH TRENT
Email: sales@wiseguyreports.com
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028
Phone: +91 841 198 5042
For more information, please visit https://www.wiseguyreports.com/sample-request/1026276-global-rnai-for-therapeutic-consumption-market-2016-industry-trend-and-forecast
Source: MarketersMedia
Release ID: 183646